This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Nov;13(11):e460-1; author reply e461-2.

doi: 10.1016/S1470-2045(12)70459-X.

Treatment options in elderly patients with glioblastoma

Aman Sharma, Daya Nand Sharma, Parmod Kumar Julka, Goura Kishor Rath

PMID: 23116998
DOI: 10.1016/S1470-2045(12)70459-X

Comment

Treatment options in elderly patients with glioblastoma

Aman Sharma et al. Lancet Oncol. 2012 Nov.

. 2012 Nov;13(11):e460-1; author reply e461-2.

doi: 10.1016/S1470-2045(12)70459-X.

Authors

Aman Sharma, Daya Nand Sharma, Parmod Kumar Julka, Goura Kishor Rath

PMID: 23116998
DOI: 10.1016/S1470-2045(12)70459-X

No abstract available

PubMed Disclaimer

Comment on

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.
Malmström A, Grønberg BH, Marosi C, Stupp R, Frappaz D, Schultz H, Abacioglu U, Tavelin B, Lhermitte B, Hegi ME, Rosell J, Henriksson R; Nordic Clinical Brain Tumour Study Group (NCBTSG). Malmström A, et al. Lancet Oncol. 2012 Sep;13(9):916-26. doi: 10.1016/S1470-2045(12)70265-6. Epub 2012 Aug 8. Lancet Oncol. 2012. PMID: 22877848 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information